JPS59155268A - 薬剤注入装置 - Google Patents
薬剤注入装置Info
- Publication number
- JPS59155268A JPS59155268A JP59002528A JP252884A JPS59155268A JP S59155268 A JPS59155268 A JP S59155268A JP 59002528 A JP59002528 A JP 59002528A JP 252884 A JP252884 A JP 252884A JP S59155268 A JPS59155268 A JP S59155268A
- Authority
- JP
- Japan
- Prior art keywords
- drug
- transdermal
- thin layer
- ointment
- dosing device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 51
- 229940079593 drug Drugs 0.000 title claims abstract description 50
- 238000002347 injection Methods 0.000 title 1
- 239000007924 injection Substances 0.000 title 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 claims abstract description 35
- 239000002674 ointment Substances 0.000 claims abstract description 31
- 239000000006 Nitroglycerin Substances 0.000 claims abstract description 25
- 229960003711 glyceryl trinitrate Drugs 0.000 claims abstract description 25
- 238000012546 transfer Methods 0.000 claims abstract description 6
- 239000006071 cream Substances 0.000 claims abstract description 5
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 claims abstract description 3
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 claims abstract description 3
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 claims abstract description 3
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 claims abstract description 3
- 229960002646 scopolamine Drugs 0.000 claims abstract description 3
- GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 claims abstract 2
- 229960002896 clonidine Drugs 0.000 claims abstract 2
- 239000000123 paper Substances 0.000 claims description 15
- 229910052782 aluminium Inorganic materials 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 11
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 10
- 239000011888 foil Substances 0.000 claims description 9
- 239000006260 foam Substances 0.000 claims description 8
- 239000011111 cardboard Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 239000004033 plastic Substances 0.000 claims description 5
- 229920003023 plastic Polymers 0.000 claims description 5
- 239000004812 Fluorinated ethylene propylene Substances 0.000 claims description 3
- 239000004264 Petrolatum Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 229920009441 perflouroethylene propylene Polymers 0.000 claims description 3
- 229940066842 petrolatum Drugs 0.000 claims description 3
- 235000020046 sherry Nutrition 0.000 claims description 3
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 claims description 3
- 229920002313 fluoropolymer Polymers 0.000 claims description 2
- 239000006261 foam material Substances 0.000 claims description 2
- 239000003871 white petrolatum Substances 0.000 claims description 2
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 claims 1
- -1 methatone Chemical compound 0.000 claims 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims 1
- USSIQXCVUWKGNF-UHFFFAOYSA-N 6-(dimethylamino)-4,4-diphenylheptan-3-one Chemical compound C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 USSIQXCVUWKGNF-UHFFFAOYSA-N 0.000 abstract 1
- 239000005030 aluminium foil Substances 0.000 abstract 1
- 229960001797 methadone Drugs 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 22
- 239000010410 layer Substances 0.000 description 17
- 239000000853 adhesive Substances 0.000 description 11
- 238000010521 absorption reaction Methods 0.000 description 8
- 230000001070 adhesive effect Effects 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 229920000715 Mucilage Polymers 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 239000004809 Teflon Substances 0.000 description 3
- 229920006362 Teflon® Polymers 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- KLDXJTOLSGUMSJ-JGWLITMVSA-N Isosorbide Chemical compound O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 KLDXJTOLSGUMSJ-JGWLITMVSA-N 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 239000012790 adhesive layer Substances 0.000 description 2
- 238000013270 controlled release Methods 0.000 description 2
- 210000001061 forehead Anatomy 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229960002479 isosorbide Drugs 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000001839 systemic circulation Effects 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 230000037317 transdermal delivery Effects 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010033372 Pain and discomfort Diseases 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000007905 drug manufacturing Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229920001821 foam rubber Polymers 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000010224 hepatic metabolism Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000000774 hypoallergenic effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000013160 medical therapy Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 201000003152 motion sickness Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 229940072991 nitro-bid Drugs 0.000 description 1
- 229940072981 nitro-dur Drugs 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 231100000245 skin permeability Toxicity 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000009121 systemic therapy Methods 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 208000023409 throat pain Diseases 0.000 description 1
- 230000005641 tunneling Effects 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Materials For Medical Uses (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IE94/83 | 1983-01-18 | ||
| IE94/83A IE54286B1 (en) | 1983-01-18 | 1983-01-18 | Drug delivery device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59155268A true JPS59155268A (ja) | 1984-09-04 |
| JPH0442025B2 JPH0442025B2 (cs) | 1992-07-10 |
Family
ID=11006807
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59002528A Granted JPS59155268A (ja) | 1983-01-18 | 1984-01-10 | 薬剤注入装置 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US4822617A (cs) |
| EP (1) | EP0117027B1 (cs) |
| JP (1) | JPS59155268A (cs) |
| AT (1) | ATE39326T1 (cs) |
| BE (1) | BE896578A (cs) |
| CH (1) | CH661446A5 (cs) |
| DE (1) | DE3475692D1 (cs) |
| IE (1) | IE54286B1 (cs) |
| PH (1) | PH23952A (cs) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6443941U (cs) * | 1987-09-11 | 1989-03-16 | ||
| JP2002539239A (ja) * | 1999-03-18 | 2002-11-19 | エルテーエス ローマン テラピー−ジステーメ アーゲー | 経皮治療システムおよびその製造方法 |
| JP2011509785A (ja) * | 2008-01-23 | 2011-03-31 | デベヴェ・テクノロジーズ | エレクトロスプレーによるパッチを作るための方法 |
| JP2021501037A (ja) * | 2017-10-31 | 2021-01-14 | オトマグネティクス，インコーポレイテッド | 皮膚へのおよび皮膚を通した磁気補助送達 |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8620227D0 (en) * | 1986-08-20 | 1986-10-01 | Smith & Nephew Ass | Wound dressing |
| DE3762480D1 (de) * | 1986-08-23 | 1990-06-07 | Arno W Latzke | Mittel zur applikation von transdermal resorbierbaren wirkstoffen. |
| US6117448A (en) * | 1986-08-28 | 2000-09-12 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Transdermal therapeutic system, its use and production process |
| US6110488A (en) * | 1986-08-28 | 2000-08-29 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Transdermal therapeutic system, its use and production process |
| US5820876A (en) * | 1986-08-28 | 1998-10-13 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Transdermal therapeutic system |
| US6126963A (en) * | 1986-08-28 | 2000-10-03 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Transdermal therapeutic system, its use and production process |
| DE3629304A1 (de) * | 1986-08-28 | 1988-03-24 | Lohmann Gmbh & Co Kg | Transdermales therapeutisches system, seine verwendung und verfahren zu seiner herstellung |
| US6139868A (en) * | 1986-08-28 | 2000-10-31 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Transdermal therapeutic system, its use and production process |
| US4908027A (en) * | 1986-09-12 | 1990-03-13 | Alza Corporation | Subsaturated transdermal therapeutic system having improved release characteristics |
| US5344656A (en) * | 1986-09-12 | 1994-09-06 | Alza Corporation | Subsaturated transdermal therapeutic system having improved release characteristics |
| GB8622698D0 (en) * | 1986-09-20 | 1986-10-29 | Smith & Nephew Ass | Dispenser |
| IL86170A (en) * | 1987-05-01 | 1992-12-01 | Elan Transdermal Ltd | Preparations and compositions comprising nicotine for percutaneous administration |
| DE3716575C2 (de) * | 1987-05-18 | 1996-01-11 | Liedtke Pharmed Gmbh | Verbandpflaster |
| KR970008118B1 (ko) * | 1987-07-09 | 1997-05-21 | 엘테에스 로오만 테라피-지스테메 게엠베하 운트 콤파니 카게 | 피부 침투성 치료 시스템 |
| USRE34692E (en) * | 1987-07-09 | 1994-08-09 | Lts Lohmann Therapi-Systeme Gmbh & Co. Kg | Transdermal therapeutic system |
| US4781924A (en) | 1987-11-09 | 1988-11-01 | Alza Corporation | Transdermal drug delivery device |
| DE3811564C2 (de) * | 1988-04-06 | 1996-02-01 | Liedtke Pharmed Gmbh | Pflaster für Arzneiformulierungen |
| JP2524190B2 (ja) * | 1988-05-11 | 1996-08-14 | 日東電工株式会社 | クロニジンを含有する粘着テ―プ製剤 |
| US5175052A (en) * | 1988-05-11 | 1992-12-29 | Nitto Denko Corporation | Adhesive tape preparation of clonidine |
| US5004610A (en) * | 1988-06-14 | 1991-04-02 | Alza Corporation | Subsaturated nicotine transdermal therapeutic system |
| US5332577A (en) * | 1988-12-27 | 1994-07-26 | Dermamed | Transdermal administration to humans and animals |
| US5241925A (en) * | 1988-12-27 | 1993-09-07 | Dermamed | Apparatus and techniques for administering veterinary medicaments |
| DE3844247A1 (de) * | 1988-12-29 | 1990-07-12 | Minnesota Mining & Mfg | Vorrichtung, insbesondere pflaster zum transdermalen verabreichen eines medikaments |
| US5230896A (en) * | 1989-10-12 | 1993-07-27 | Warner-Lambert Company | Transdermal nicotine delivery system |
| US5324521A (en) * | 1989-12-18 | 1994-06-28 | Dermamed | Systems for transdermal administration of medicaments |
| IE82916B1 (en) * | 1990-11-02 | 2003-06-11 | Elan Corp Plc | Formulations and their use in the treatment of neurological diseases |
| US5508038A (en) * | 1990-04-16 | 1996-04-16 | Alza Corporation | Polyisobutylene adhesives for transdermal devices |
| US5403595A (en) * | 1991-05-07 | 1995-04-04 | Dynagen, Inc. | Controlled, sustained release delivery system for smoking cessation |
| US5486362A (en) * | 1991-05-07 | 1996-01-23 | Dynagen, Inc. | Controlled, sustained release delivery system for treating drug dependency |
| US5780051A (en) * | 1992-04-02 | 1998-07-14 | Dynagen, Inc. | Methods and articles of manufacture for nicotine cessation and monitoring nicotine use |
| US5883115A (en) * | 1992-11-09 | 1999-03-16 | Pharmetrix Division Technical Chemicals & Products, Inc. | Transdermal delivery of the eutomer of a chiral drug |
| US5502626A (en) * | 1994-06-17 | 1996-03-26 | Honeywell Inc. | High efficiency fluorescent lamp device |
| JP3112393B2 (ja) * | 1995-05-25 | 2000-11-27 | シャープ株式会社 | カラー表示装置 |
| DE19642043A1 (de) | 1995-10-23 | 1997-04-24 | Hexal Ag | Transdermales therapeutisches System (TTS) für die Verabreichung von Wirkstoffen zur Behandlung von Drogenabhängigkeit oder Drogensucht |
| US5730721A (en) * | 1996-01-25 | 1998-03-24 | Vesture Corporation | Medical applicator and method |
| US5891472A (en) * | 1996-11-19 | 1999-04-06 | Meri Charmyne Russell | Treatment of equine laminitis |
| US5971722A (en) * | 1997-09-05 | 1999-10-26 | Baxter International Inc | Electrochemical syringe pump having a sealed storage reservoir for a charge transfer medium |
| DE69916025T2 (de) * | 1998-01-30 | 2004-10-28 | Coloplast A/S | Gegenstand mit einer Oberfläche mit Klebeeigenschaften |
| GB9802078D0 (en) * | 1998-01-30 | 1998-03-25 | Futura Medical Limited | Preparation for treatment of erectile dysfunction |
| US6635274B1 (en) | 2000-10-27 | 2003-10-21 | Biochemics, Inc. | Solution-based transdermal drug delivery system |
| US20050065175A1 (en) * | 2003-09-24 | 2005-03-24 | Xanodyne Pharmacal, Inc. | Oral transmucosal methadone |
| US8007826B2 (en) | 2003-12-11 | 2011-08-30 | Acorda Therapeutics, Inc. | Sustained release aminopyridine composition |
| US8354437B2 (en) | 2004-04-09 | 2013-01-15 | Acorda Therapeutics, Inc. | Method of using sustained release aminopyridine compositions |
| US7838719B2 (en) * | 2005-10-03 | 2010-11-23 | Hilton Jr Jimmy Earl | Bandage for covering a wound with no adhesive-to-skin contact |
| FR2924349B1 (fr) | 2007-12-03 | 2010-01-01 | Dbv Tech | Methode de desensibilitation aux allergenes |
| WO2010046921A2 (en) | 2008-10-14 | 2010-04-29 | Sagar Suresh Patil | Applicator for cream / ointment |
| US20100100060A1 (en) * | 2008-10-17 | 2010-04-22 | Novartis Ag | Applicator for pharmaceutical product and method of using same |
| DE102010053792A1 (de) | 2010-12-08 | 2012-06-14 | Frank Becher | Flächiges wirkstoffhaltiges System zur Entkeimung von Kontaktflächen |
| WO2013072763A2 (en) * | 2011-11-16 | 2013-05-23 | Nometics Inc. | Non-sensitizing transdermal clonidine patch |
| CN105521552A (zh) * | 2014-08-14 | 2016-04-27 | 王丽 | 用于美容的节约用药的医疗设备 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2561071A (en) * | 1949-09-21 | 1951-07-17 | Prisk Howard Conley | Holder for subcutaneous administration of medicaments |
| US2782377A (en) * | 1951-06-29 | 1957-02-19 | Myron C Selby | Micropotentiometers |
| US3734097A (en) * | 1969-04-01 | 1973-05-22 | Alza Corp | Therapeutic adhesive tape |
| US3964482A (en) * | 1971-05-17 | 1976-06-22 | Alza Corporation | Drug delivery device |
| US3742951A (en) * | 1971-08-09 | 1973-07-03 | Alza Corp | Bandage for controlled release of vasodilators |
| US3996934A (en) * | 1971-08-09 | 1976-12-14 | Alza Corporation | Medical bandage |
| US3814095A (en) * | 1972-03-24 | 1974-06-04 | H Lubens | Occlusively applied anesthetic patch |
| US3910284A (en) * | 1973-01-22 | 1975-10-07 | Norman Orentreich | Method of treating human skin |
| GB1519149A (en) * | 1974-11-30 | 1978-07-26 | Fisons Ltd | Devices for administering medicaments |
| AR207805A1 (es) * | 1975-02-06 | 1976-10-29 | Alza Corp | Substrato apropiado para formar apositos para la dispensacion continua de escopolamina base por via transdermica |
| US4031894A (en) * | 1975-12-08 | 1977-06-28 | Alza Corporation | Bandage for transdermally administering scopolamine to prevent nausea |
| IL59063A (en) * | 1979-01-11 | 1983-12-30 | Key Pharma | Polymeric diffusion matrix for release of pharmaceutical dosage |
| DE2902183A1 (de) * | 1979-01-20 | 1980-07-31 | Geb Schmidt Beate D Ringwelski | Vorrichtung zum aufbringen bzw. halten von nitrit- und/oder nitratverbindungen auf der haut |
| US4341208A (en) * | 1980-07-14 | 1982-07-27 | Whitman Medical Corporation | Moisture-retentive covering for ointment application |
| JPS5777617A (en) * | 1980-10-20 | 1982-05-15 | Nichiban Co Ltd | Plaster for cardiac disease |
| US4460372A (en) * | 1981-02-17 | 1984-07-17 | Alza Corporation | Percutaneous absorption enhancer dispenser for use in coadministering drug and percutaneous absorption enhancer |
| US4486193A (en) * | 1981-07-22 | 1984-12-04 | Alza Corporation | Method for treating ischemic conditions by administering drug by two routes |
| JPH04138120A (ja) * | 1990-09-28 | 1992-05-12 | Nippon Isueede Kk | 便座用敷紙繰出し装置 |
-
1983
- 1983-01-18 IE IE94/83A patent/IE54286B1/en not_active IP Right Cessation
- 1983-04-27 BE BE0/210638A patent/BE896578A/fr not_active IP Right Cessation
- 1983-12-27 CH CH6937/83A patent/CH661446A5/fr not_active IP Right Cessation
-
1984
- 1984-01-06 EP EP84300083A patent/EP0117027B1/en not_active Expired
- 1984-01-06 AT AT84300083T patent/ATE39326T1/de not_active IP Right Cessation
- 1984-01-06 DE DE8484300083T patent/DE3475692D1/de not_active Expired
- 1984-01-09 PH PH30075A patent/PH23952A/en unknown
- 1984-01-10 JP JP59002528A patent/JPS59155268A/ja active Granted
-
1987
- 1987-04-10 US US07/037,108 patent/US4822617A/en not_active Expired - Lifetime
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6443941U (cs) * | 1987-09-11 | 1989-03-16 | ||
| JP2002539239A (ja) * | 1999-03-18 | 2002-11-19 | エルテーエス ローマン テラピー−ジステーメ アーゲー | 経皮治療システムおよびその製造方法 |
| JP4861553B2 (ja) * | 1999-03-18 | 2012-01-25 | エルテーエス ローマン テラピー−ジステーメ アーゲー | 経皮治療システムおよびその製造方法 |
| JP2011509785A (ja) * | 2008-01-23 | 2011-03-31 | デベヴェ・テクノロジーズ | エレクトロスプレーによるパッチを作るための方法 |
| JP2021501037A (ja) * | 2017-10-31 | 2021-01-14 | オトマグネティクス，インコーポレイテッド | 皮膚へのおよび皮膚を通した磁気補助送達 |
| US11717696B2 (en) | 2017-10-31 | 2023-08-08 | Otomagnetics, Inc. | Magnetically-assisted delivery into and through the skin |
Also Published As
| Publication number | Publication date |
|---|---|
| US4822617A (en) | 1989-04-18 |
| IE830094L (en) | 1984-07-18 |
| CH661446A5 (fr) | 1987-07-31 |
| JPH0442025B2 (cs) | 1992-07-10 |
| EP0117027B1 (en) | 1988-12-21 |
| EP0117027A1 (en) | 1984-08-29 |
| IE54286B1 (en) | 1989-08-16 |
| PH23952A (en) | 1990-01-23 |
| ATE39326T1 (de) | 1989-01-15 |
| BE896578A (fr) | 1983-08-16 |
| DE3475692D1 (en) | 1989-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS59155268A (ja) | 薬剤注入装置 | |
| JP2513712B2 (ja) | 創傷用ドレッシング | |
| JP3786684B2 (ja) | オキシブチニンの経皮投与 | |
| US5120544A (en) | Crosslinked hydrogel and method for making same | |
| US4690683A (en) | Transdermal varapamil delivery device | |
| US5662925A (en) | Transdermal delivery system with adhesive overlay and peel seal disc | |
| US6120792A (en) | Medicated skin patch and method for its use | |
| US4592753A (en) | Drug delivery device | |
| US4230105A (en) | Transdermal delivery of drugs | |
| US6416749B1 (en) | Treatment for onychomycosis topically applying salicylic acid, optionally in combination with a retinoid | |
| JP2547726B2 (ja) | フェンタニルの皮膚投与およびそのための装置 | |
| US4826677A (en) | Pharmaceutical material for the treatment of psoriasis | |
| US5069908A (en) | Crosslinked hydrogel and method for making same | |
| CA1092466A (en) | Topical device for administering tretinoin | |
| JP2683264B2 (ja) | 皮膚に活性物質を一定に投与するための活性物質含有プラスター | |
| US4910205A (en) | Transdermal delivery of loratadine | |
| JP2003525641A (ja) | 爪真菌症の治療用感圧接着性マトリックス・パッチ | |
| JP2007520262A (ja) | 経皮または局所薬物輸送に伴う副作用の処置方法 | |
| US5863941A (en) | Method and composition of a topical treatment of inner ear and labyrinth symptoms | |
| JP2001527581A (ja) | メントの経皮投与 | |
| Monkhouse et al. | Transdermal drug delivery-problems and promises | |
| AU618273B2 (en) | Transdermal administration using benzyl alcohol | |
| US6299899B1 (en) | Extremely flexible plaster acting dermally or transdermally, and method for producing same | |
| US6572580B2 (en) | Set depth nail notcher with patch system and method for treating nail fungus | |
| CA2480683A1 (en) | Assembled unit consisting of individually separable transdermal therapeutic systems |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |